Chargement en cours...
Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co‐formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial
AIMS: To evaluate the efficacy and safety of two insulin intensification strategies for patients with type 2 diabetes previously treated with basal insulin – insulin degludec (IDeg) and insulin aspart (IAsp) – administered as a co‐formulation (IDegAsp) or as a basal‐bolus regimen (IDeg and IAsp in s...
Enregistré dans:
| Publié dans: | Diabetes Obes Metab |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Publishing Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066701/ https://ncbi.nlm.nih.gov/pubmed/26592732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12609 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|